Home > Publications database > Corrigendum to 'Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease' [Eur. J. Med. Chem. 275 (2024) 116624]. > print

001     305373
005     20251113152100.0
024 7 _ |a 10.1016/j.ejmech.2025.118254
|2 doi
024 7 _ |a pmid:41087268
|2 pmid
024 7 _ |a 0009-4374
|2 ISSN
024 7 _ |a 0223-5234
|2 ISSN
024 7 _ |a 1768-3254
|2 ISSN
037 _ _ |a DKFZ-2025-02114
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Liang, Ting
|b 0
245 _ _ |a Corrigendum to 'Multimechanism biological profiling of tetrahydro-β-carboline analogues as selective HDAC6 inhibitors for the treatment of Alzheimer's disease' [Eur. J. Med. Chem. 275 (2024) 116624].
260 _ _ |a Amsterdam [u.a.]
|c 2026
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1763043566_4080001
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Volume 301, 5 January 2026, 118254
520 _ _ |a The authors regret that Dr. Aubry K. Miller was omitted from the list of authors. And he was the supervisor of Raphael R. Steimbach, who himself conducted the HDAC10 ligand displacement assay. And Dr. Aubry K. Miller checked the quality of the experimental data and provided the financial resources for conducting the experiments. The correct authorship is provided below:< Ting Lianga, Shiru Liua, Baiyun Danga, Xiaofa Luana, Yifan Guoa, Raphael R. Steimbachb, c, Aubry K. Millerb, Jiadong Hud, Long Lud, Peiyu Yued, Ruotian Wangd, Meng Zhenga, Jinming Gaoa, *, Xia Yina, *, Xin Chena, *>aShaanxi Key Labotory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, P. R. ChinabCancer Drug Development Group, German Cancer Research Center (DKFZ), 69120, Heidelberg, GermanycBiosciences Faculty, University of Heidelberg, 69120, Heidelberg, GermanydSchool of Medicinal and Chemical Engineering, Yangling Vocational & Technical College, Yangling 712100, P. R. China>.The authors would like to apologise for any inconvenience caused.The correct CRediT authorship contribution statement is as follows. Ting Liang: Writing – original draft, Investigation, Formal analysis, Data curation. Shiru Liu: Data curation. Baiyun Dang: Data curation. Xiaofa Luan: Data curation. Yifan Guo: Data curation. Raphael R. Steimbach: Data curation. Aubry K. Miller: Supervision. Jiadong Hu: Data curation. Long Lu: Data curation. Peiyu Yue: Data curation. Ruotian Wang: Data curation. Meng Zheng: Data curation. Jinming Gao: Conceptualization. Xia Yin: Validation, Supervision. Xin Chen: Writing – review & editing, Funding acquisition.
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Liu, Shiru
|b 1
700 1 _ |a Dang, Baiyun
|b 2
700 1 _ |a Luan, Xiaofa
|b 3
700 1 _ |a Guo, Yifan
|b 4
700 1 _ |a Steimbach, Raphael
|0 P:(DE-He78)3568511512db56dcce22bfd8cd010c01
|b 5
700 1 _ |a Miller, Aubry
|0 P:(DE-He78)f0af962ddbc82430e947390b2f3f6e49
|b 6
|u dkfz
700 1 _ |a Hu, Jiadong
|b 7
700 1 _ |a Lu, Long
|b 8
700 1 _ |a Yue, Peiyu
|b 9
700 1 _ |a Wang, Ruotian
|b 10
700 1 _ |a Zheng, Meng
|b 11
700 1 _ |a Gao, Jinming
|b 12
700 1 _ |a Yin, Xia
|b 13
700 1 _ |a Chen, Xin
|b 14
773 _ _ |a 10.1016/j.ejmech.2025.118254
|g p. 118254 -
|0 PERI:(DE-600)2005170-0
|p 118254
|t European journal of medicinal chemistry
|v 301
|y 2026
|x 0009-4374
909 C O |p VDB
|o oai:inrepo02.dkfz.de:305373
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)3568511512db56dcce22bfd8cd010c01
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)f0af962ddbc82430e947390b2f3f6e49
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1200
|2 StatID
|b Chemical Reactions
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1210
|2 StatID
|b Index Chemicus
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J MED CHEM : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J MED CHEM : 2022
|d 2025-01-07
920 1 _ |0 I:(DE-He78)A390-20160331
|k A390
|l AG Wirkstoffforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A390-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21